Proliferative Vitreoretinopathy (PVR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Proliferative Vitreoretinopathy (PVR) pipeline market research report provides an overview of the Proliferative Vitreoretinopathy (PVR) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Proliferative Vitreoretinopathy (PVR), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Proliferative Vitreoretinopathy (PVR) and features dormant and discontinued projects.
PVR Pipeline Drugs Market by Key Targets
The targets of the PVR pipeline drugs market are Cannabinoid Receptor 1, Cannabinoid Receptor 2, Dihydrofolate Reductase, E3 Ubiquitin Protein Ligase Mdm2, Mitogen Activated Protein Kinase Kinase Kinase 7, Platelet Derived Growth Factor), Transforming Growth Factor Beta 1, and Transforming Growth Factor Beta 2.
PVR Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key Mechanisms of Action in the PVR Pipeline Drugs Market
The mechanisms of action of the PVR pipeline drugs market are Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Dihydrofolate Reductase Inhibitor, E3 Ubiquitin Protein Ligase Mdm2 Inhibitor, Mitogen Activated Protein Kinase Kinase Kinase 7 Inhibitor, Platelet Derived Growth Factor Inhibitor, Transforming Growth Factor Beta 1 Inhibitor, and Transforming Growth Factor Beta 2 Inhibitor. Cannabinoid Receptor 1 Agonist has the highest number of pipeline products.
PVR Pipeline Drugs Market, by Mechanisms of Action
For more mechanisms of action insights, download a free report sample
Key Routes of Administration in the PVR Pipeline Drugs Market
The routes of administration in the PVR pipeline drugs market are intravenous, intravitreal, and ophthalmic.
PVR Pipeline Drugs Market, by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the PVR Pipeline Drugs Market
The molecule types in the PVR pipeline drugs market are small molecule, aptamer, monoclonal antibody, and oligonucleotide.
For more molecule type insights, download a free report sample
Key PVR Pipeline Drugs Market Companies
Some of the key companies in the PVR pipeline drugs market are Aldeyra Therapeutics Inc, Aptitude Medical Systems Inc, Focal Point Pharmaceuticals Inc, Novartis AG, Panag Pharma Inc, and Ractigen Therapeutics Inc.
PVR Pipeline Drugs Market, by Key Companies
To know more about key companies, download a free report sample
Market Report Overview
Key Targets | Cannabinoid Receptor 1, Cannabinoid Receptor 2, Dihydrofolate Reductase, E3 Ubiquitin Protein Ligase Mdm2, Mitogen Activated Protein Kinase Kinase Kinase 7, Platelet Derived Growth Factor), Transforming Growth Factor Beta 1, and Transforming Growth Factor Beta 2 |
Key Mechanisms of Action | Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Dihydrofolate Reductase Inhibitor, E3 Ubiquitin Protein Ligase Mdm2 Inhibitor, Mitogen Activated Protein Kinase Kinase Kinase 7 Inhibitor, Platelet Derived Growth Factor Inhibitor, Transforming Growth Factor Beta 1 Inhibitor, and Transforming Growth Factor Beta 2 Inhibitor |
Key Routes of Administration | Intravenous, Intravitreal, and Ophthalmic |
Key Molecule Types | Small Molecule, Aptamer, Monoclonal Antibody, and Oligonucleotide |
Key Companies | Aldeyra Therapeutics Inc, Aptitude Medical Systems Inc, Focal Point Pharmaceuticals Inc, Novartis AG, Panag Pharma Inc, and Ractigen Therapeutics Inc |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Proliferative Vitreoretinopathy (PVR) (Ophthalmology).
- Reviews of pipeline therapeutics for Proliferative Vitreoretinopathy (PVR) (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key companies involved in Proliferative Vitreoretinopathy (PVR) (Ophthalmology) therapeutics and enlists all their major and minor projects.
- Evaluation of Proliferative Vitreoretinopathy (PVR) (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Proliferative Vitreoretinopathy (PVR) (Ophthalmology).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Proliferative Vitreoretinopathy (PVR) (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Proliferative Vitreoretinopathy (PVR) (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Aptitude Medical Systems Inc
Focal Point Pharmaceuticals Inc
Novartis AG
Panag Pharma Inc
Ractigen Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets of the PVR pipeline drugs market?
The targets of the PVR pipeline drugs market are Cannabinoid Receptor 1, Cannabinoid Receptor 2, Dihydrofolate Reductase, E3 Ubiquitin Protein Ligase Mdm2, Mitogen Activated Protein Kinase Kinase Kinase 7, Platelet Derived Growth Factor), Transforming Growth Factor Beta 1, and Transforming Growth Factor Beta 2.
-
What are the key mechanisms of action of the PVR pipeline drugs market?
The mechanisms of action of the PVR pipeline drugs market are Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Dihydrofolate Reductase Inhibitor, E3 Ubiquitin Protein Ligase Mdm2 Inhibitor, Mitogen Activated Protein Kinase Kinase Kinase 7 Inhibitor, Platelet Derived Growth Factor Inhibitor, Transforming Growth Factor Beta 1 Inhibitor, and Transforming Growth Factor Beta 2 Inhibitor.
-
What are the key routes of administration in the PVR pipeline drugs market?
The routes of administration in the PVR pipeline drugs market are intravenous, intravitreal, and ophthalmic.
-
What are the molecule types in the PVR pipeline drugs market?
The molecule types in the PVR pipeline drugs market are small molecule, aptamer, monoclonal antibody, and oligonucleotide.
-
Which are the key companies in the PVR pipeline drugs market?
Some of the key companies in the PVR pipeline drugs market are Aldeyra Therapeutics Inc, Aptitude Medical Systems Inc, Focal Point Pharmaceuticals Inc, Novartis AG, Panag Pharma Inc, and Ractigen Therapeutics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.